JAN 22, 2019 7:00 AM PST

Overcoming the challenges of accuracy and detection in molecular assays

Speaker
  • Senior Business Development Manager, Molecular Diagnostics, Licensing and Commercial Supply-UK, Ireland and Nordics
    Biography
      Peter's current role is in supporting customers who purchase Thermo Fisher Scientific products for commercial use, with a particular focus in supporting the use of molecular biology and sample preparation products for inclusion into diagnostic kits. He has over 15 years of experience in commercial sales and is responsible for Ion Torrent™ sequencing, capillary electrophoresis, real-time PCR, and molecular biology products. Prior to joining Thermo Fisher Scientific, Peter led a research group in molecular toxicology at AstraZeneca after receiving his doctorate in plant biology from the University of Edinburgh.

    Abstract
    DATE:    January 22, 2019
    TIME:    07:00am PST, 10:00am EST
     
    Molecular diagnostic tests are currently used for infectious disease testing due to the superior sensitivity and specificity that can be obtained. Due to the success that has been obtained with this application, molecular diagnostic testing is expected to grow into other areas such as genetic testing, prenatal testing, oncology, and pharmacogenomics. Growth in these areas will undoubtedly come with additional challenges due to the variety of the samples required, the presence of inhibitors, and low sample amounts, all of which contribute to potential false negative results due to poor amplification reactions.
     
    In this presentation, we will demonstrate how a change in assay components can overcome these challenges. Specifically, we will address the issues that the Nucleic Acid Amplification Test (NAAT) (a commonly used diagnostic tool used for its fast turnaround and less invasive sample collection) has faced and how a change in enzyme selection impacted the overall quality and accuracy of the molecular diagnostic assay.
     
    Learning Objectives:
    • Understand key challenges in nucleic acid amplification tests
    • Identify enzyme characteristics important for increased sensitivity, specificity, and speed
    • Understand how better PCR enzymes and reverse transcriptases can impact the accuracy and detection of molecular test assays
     

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    Loading Comments...
    Show Resources
    Attendees
    • See more